Radiopharmaceuticals: all 1,299 studies that test it
Page 9 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CTStatus unknownNCT04514614Early Phase 1
- Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine TumorsCompletedNCT04510311Early Phase 1
- [177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.CompletedNCT04509557Phase 1
- Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CTStatus unknownNCT04507932Early Phase 1
- 68Ga PSMA-11 PET/CT in Recurrent Prostate CancerWithdrawnNCT04483414Phase 2
- A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With MyelomaWithdrawnNCT04467281Phase 2
- Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple MyelomaWithdrawnNCT04466475Phase 1
- Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2CompletedNCT04461457Early Phase 1
- Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate CancerCompletedNCT04443062Phase 2
- An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine TumoursCompletedNCT04440956Early Phase 1
- A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)CompletedNCT04438304Phase 2
- Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to ProstatectomyActive, not recruitingNCT04430192Phase 1/2
- Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy ControlsActive, not recruitingNCT04401917Early Phase 1
- Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNETCompletedNCT04385992Phase 2
- 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive TumoursCompletedNCT04375267Phase 1
- Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRIWithdrawnNCT04347135Phase 1/2
- In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to ChemotherapyActive, not recruitingNCT04343885Phase 2
- 18F-fluorocholine and 18F-fluoride PET in Prostate CancerCompletedNCT04340765Not applicable
- PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver CancerCompletedNCT04310540Early Phase 1
- Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET ExaminationStatus unknownNCT04305210Phase 2
- Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOCWithdrawnNCT04298541Phase 2
- Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerCompletedNCT04282824Early Phase 1
- Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerTerminatedNCT04279561Phase 1
- Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.WithdrawnNCT04276597Phase 2
- Neuroinflammation Imaging in ADActive, not recruitingNCT04274998Early Phase 1
- Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic DisordersStatus unknownNCT04273334Phase 1
- 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast CancerCompletedNCT04267900Early Phase 1
- Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast CancerStatus unknownNCT04261179Phase 4
- PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerWithdrawnNCT04243941Phase 2
- 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung CancerCompletedNCT04233476Phase 3
- FDG PET-MRI for the Diagnosis of Spinal Cord LesionsCompletedNCT04219969Not applicable
- 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate CancerCompletedNCT04216134Phase 1
- Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine CancerStatus unknownNCT04194125Phase 2
- [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnNCT04186988Early Phase 1
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of InsulinomaStatus unknownNCT04185350Early Phase 1
- Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial SarcomaTerminatedNCT04176016Phase 1
- PET and MRI Imaging of Brain Tumors Using [18F]PARPiCompletedNCT04173104Early Phase 1
- Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment SubjectsStatus unknownNCT04169126Phase 2
- Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CTTerminatedNCT04168528Phase 1/2
- A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 ProteinCompletedNCT04147819Phase 1
- Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy SubjectsActive, not recruitingNCT04141150Phase 2
- Characterizing IgG4-RD With 68Ga-FAPI PET/CTStatus unknownNCT04125511Early Phase 1
- Safety and Targeting of Anti-hk2 Antibody in mCRPCTerminatedNCT04116164Early Phase 1
- Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With GliomaCompletedNCT04114370Early Phase 1
- Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersWithdrawnNCT04106843Phase 2
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CTTerminatedNCT04105634Early Phase 1
- Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry PlanningCompletedNCT04105283Phase 1
- F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical RecurrenceCompletedNCT04102553Phase 3
- Mapping Draining Lymph Nodes in CNS MalignanciesTerminatedNCT04096716Phase 1
- Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CTActive, not recruitingNCT04062526Early Phase 1
- Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung CancerStatus unknownNCT04052412Phase 1
- 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerCompletedNCT04050215Phase 2
- The Causal Connection Between Sng and Muscle AcidosisStatus unknownNCT04049253Not applicable
- Fluoroethyltyrosine for Evaluation of Intracranial NeoplasmsCompletedNCT04044937Phase 2
- 68Ga-DOTATATE PET/CT in Neuroendocrine TumorStatus unknownNCT04041882Early Phase 1
- An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsActive, not recruitingNCT04040088Early Phase 1
- Carcinoid Heart Disease and Peptide Receptor Radiotargetted TherapyStatus unknownNCT04039516Phase 2
- Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR OverexpressionStatus unknownNCT04029428Phase 2
- 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory NeuroblastomaTerminatedNCT04023331Phase 1/2
- 68-Ga-FAPI PET Imaging in MalignancyWithdrawnNCT04023240Phase 2
- A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated MalariaWithdrawnNCT04020653Phase 2
- Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With GlioblastomaCompletedNCT04019002Phase 1
- Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4SuspendedNCT04017819Phase 1
- The Impact of a Low or High Phosphate Diet on Phosphate and Calcium Excretion in Healthy PeopleStatus unknownNCT04013776Not applicable
- Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid TumorCompletedNCT04013048Phase 1
- 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell CarcinomaActive, not recruitingNCT04006522Phase 2
- An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal CancerCompletedNCT03993327Phase 1
- Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to ColonoscopyCompletedNCT03992365Phase 3
- [18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )CompletedNCT03990285Phase 1
- A Study of 99mTc-3PRGD2 Injection in Healthy VolunteersCompletedNCT03974685Phase 1
- Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk MeningiomaActive, not recruitingNCT03971461Phase 2
- Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™CompletedNCT03936426Phase 1/2
- 18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation NecrosisCompletedNCT03930173Early Phase 1
- Tau Imaging With JNJ067CompletedNCT03926702Early Phase 1
- 18F-Fluciclovine PET and Multiparametric MR ImagingWithdrawnNCT03925675Phase 2
- Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and AdolescentsWithdrawnNCT03923257Phase 1/2
- Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's DiseaseCompletedNCT03903211Phase 2
- Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine TumorsCompletedNCT03883776Phase 1
- Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate CancerCompletedNCT03860987Phase 2
- 18F-DCFPyL PET-CT Scan and Prostate CancerStatus unknownNCT03852654Phase 2/3
- Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate CancerCompletedNCT03828838Phase 1/2
- Randomized Controlled Trail of Polyethylene Glycol vs Sodium Phosphate for Colonic Cleansing of ColonoscopyCompletedNCT03817788Phase 4
- Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerWithdrawnNCT03800784Phase 2/3
- Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate CancerCompletedNCT03793543Phase 1
- Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission TomographyCompletedNCT03779815Not applicable
- PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate CancerCompletedNCT03768349Early Phase 1
- Brain Imaging in the Diabetes Prevention Program Outcomes StudyTerminatedNCT03757910Early Phase 1
- [C-11]PiB PET Imaging in Alcohol Use DisordersCompletedNCT03746366Early Phase 1
- Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPECCompletedNCT03732781Phase 1/2
- Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal CarcinomatosisCompletedNCT03732768Phase 1
- Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver MetastasesTerminatedNCT03724409Early Phase 1
- Imaging With [11C]Martinostat in Breast CancerWithdrawnNCT03721211Phase 1
- 124I-p5+14 Injection Safety in Subjects With Systemic AmyloidosisCompletedNCT03678259Phase 1/2
- Reliability of [18F]-FTC-146 Brain Uptake in Healthy ControlsCompletedNCT03649555Phase 1
- 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid CancerCompletedNCT03647657Early Phase 1
- 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal ControlsCompletedNCT03625128Early Phase 1
- Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue SarcomaWithdrawnNCT03613259Early Phase 1
- A Dose Finding Study of CycloSam® Combined With External Beam RadiotherapyWithdrawnNCT03612466Phase 1
- Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver MetastasesCompletedNCT03590119Phase 2/3
- Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based BiomarkersActive, not recruitingNCT03585114Phase 2